Form 4: USANA Health Sciences Director Acquires Restricted Stock Units

USANA Health Sciences Director Frederic J. Winssinger acquired 6,527 restricted stock units on May 7, 2026, as detailed in a Form 4 filing.

Summary

• Frederic J. Winssinger, a Director at USANA Health Sciences Inc. (USNA), acquired 6,527 restricted stock units (RSUs) on May 7, 2026.
• These RSUs represent a contingent right to receive one share of USNA common stock per unit.
• The RSUs are set to vest in four equal installments of 25% on July 23, 2026, October 22, 2026, January 21, 2027, and April 22, 2027.
• Following this transaction, Winssinger directly beneficially owns 6,527 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents a standard equity grant to a director, aligning incentives without immediate financial impact.

Positives

• Director acquisition of equity signals confidence in the company's future prospects.
• The acquisition is in the form of restricted stock units, which typically vest over time, aligning the director's incentives with long-term shareholder value.

Future Outlook

The restricted stock units are scheduled to vest over a period extending into April 2027, indicating a long-term incentive structure for the director.

Industry Context

StockSavvy.ai notes that insider acquisitions of equity, particularly in the form of RSUs, are common within the health sciences and direct selling industries as a method to retain and incentivize key leadership.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of commitment to the company's long-term performance.

Next Steps

• Vesting of restricted stock units on scheduled dates through April 2027.

Key Dates

Keywords

USANA Health Sciences, USNA, Form 4, Director, Restricted Stock Units, Equity Award, Beneficial Ownership, Insider Transaction